Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/06/1989 | EP0330725A1 Preparation and expression of DNA sequences coding for proteins having the biological properties of cystatin C |
09/06/1989 | EP0330696A1 Recombinant antibodies and methods for their production |
09/06/1989 | EP0330667A1 Peptide compounds |
09/05/1989 | US4864020 Monoclonal antibodies and cell lines for parathyroid tissue-specific antigen parathyroid-specific |
09/05/1989 | US4864019 Antibodies to inhibin and conjugates produced therefrom |
09/05/1989 | US4863950 Gelatin, l-cystine, synergistic |
09/05/1989 | US4863903 Substituted 5-amino-4-hydroxyvaleryl derivatives |
09/05/1989 | US4863902 Treatment of cancer |
09/05/1989 | US4863901 Use of growth hormone for nitrogen retention under hypocaloric conditions |
09/05/1989 | US4863900 Herpes |
09/05/1989 | US4863899 Biologically active polypeptides |
09/05/1989 | US4863898 Amino acid chelated compositions for delivery to specific biological tissue sites |
09/05/1989 | US4863897 Protein and mineral water-containing cosmetic compositions |
09/05/1989 | US4863896 Diabetic control by combined insulin forms |
09/05/1989 | US4863857 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known |
09/05/1989 | US4863740 Interleukin therapy |
09/05/1989 | US4863736 Grothw regulators, milk production |
09/05/1989 | US4863732 Injectable composition for inductive bone repair |
09/05/1989 | US4863730 Antibodies |
09/05/1989 | US4863729 Method for preparing a macromolecular monoclonal antibody composition |
09/05/1989 | US4863727 Combination therapy using interleukin-2 and tumor necrosis factor |
09/05/1989 | US4863726 Combination therapy using immunotoxins with interleukin-2 |
09/05/1989 | US4863609 Process for the fractional separation of protein mixtures by means of membranes |
08/30/1989 | EP0330647A2 The use of chymotrypsin for the inactivation of prekallikrein activator |
08/30/1989 | EP0330521A2 Antihypertensive hyperimmune milk |
08/30/1989 | EP0330432A1 Improvements relating to the control of neoplastic tissue growth |
08/30/1989 | EP0330396A2 DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI |
08/30/1989 | EP0330389A2 Human collagen processing and autoimplant use |
08/30/1989 | EP0330359A2 Composition useful in the diagnosis and treating of HIV-1 infection |
08/30/1989 | EP0330241A2 Calcitonin derivatives |
08/30/1989 | EP0330227A2 Derivatives of soluble T-4 |
08/30/1989 | EP0330191A2 DNA encoding CD40 |
08/30/1989 | EP0330049A2 Factor XIII for the prevention of intraventricular hemorrhage |
08/30/1989 | EP0329994A1 Immunogen and its use in preparing antibodies to haemoglobin A1C |
08/30/1989 | EP0329778A1 Molecular decoyants and methods of use thereof |
08/30/1989 | EP0329760A1 Suppressive t lymphocyte cell lines and supernatant derivative thereof |
08/30/1989 | EP0329693A1 Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same |
08/30/1989 | EP0247074B1 De-(acetylglucosaminyl)-di(dehydro)-deoxy teicoplanin derivatives |
08/30/1989 | EP0204788B1 New hypocalcemic polypeptides, preparation thereof and drugs containing these active principles |
08/30/1989 | CN1035128A Monoclonal antibodies, a method for the preparation thereof and use thereof |
08/30/1989 | CN1035050A Double chain rna correction circulation immunity compound and mononuclear cell function disorder |
08/29/1989 | US4861865 Novel antithrombin peptide |
08/29/1989 | US4861757 Wound healing and bone regeneration using PDGF and IGF-I |
08/29/1989 | US4861756 Synthetic pulmonary surfactant |
08/29/1989 | US4861755 Peptides with vasorelaxant, natriuretic and diuretic effects a process for their preparation, agents containing them, and their use |
08/29/1989 | US4861720 Oncornavirus vaccines and feline alpha-type interferon |
08/29/1989 | US4861710 Recombinant DNA clone encoding laminin receptor |
08/29/1989 | US4861587 Use of TNF for the prevention or treatment of radiation damage |
08/29/1989 | US4861580 Composition using salt form of organic acid derivative of alpha-tocopheral |
08/29/1989 | US4861579 Suppression of B-lymphocytes in mammals by administration of anti-B-lymphocyte antibodies |
08/29/1989 | CA1258950A1 Substituted tyrosyl alanine dipeptide amides |
08/29/1989 | CA1258948A1 Hydroxy substituted peptide compounds |
08/24/1989 | WO1989007641A1 Enhancement of the therapeutic properties of glycoprotein |
08/24/1989 | WO1989007613A1 Proteins which induce immunological effector cell activation and chemattraction |
08/24/1989 | WO1989007611A1 Prepromotilin and motilin-associated peptide (map) |
08/24/1989 | WO1989007609A1 Homoarginine-based peptides as platelet aggregation inhibitors |
08/24/1989 | WO1989007608A1 Blocking, isolating and purifying calcium channels |
08/24/1989 | WO1989007592A1 Improvements relating to the control of neoplastic tissue growth |
08/24/1989 | WO1989007454A1 Pharmaceutical composition for treatment of lung obstructions |
08/24/1989 | WO1989007452A1 Improvements in or relating to antibodies |
08/24/1989 | WO1989007451A1 Reduced size lhrh analogs |
08/24/1989 | WO1989007450A1 Lhrh analogs |
08/24/1989 | WO1989007449A1 Methods for treating immunoinflammatory and other disease conditions |
08/24/1989 | WO1989007448A1 Use of synthetic peptides to generate and manipulate cellular immunity |
08/24/1989 | WO1989007445A1 Improved method for treatment of cancer with activated oncolytic leukocytes |
08/24/1989 | WO1989007136A3 Modified hepatocytes and uses therefor |
08/23/1989 | EP0329609A2 Antiviral combination |
08/23/1989 | EP0329605A1 Process for the preparation of apolipoproteins from blood plasma or serum fractions |
08/23/1989 | EP0329413A2 Polypeptides with cell-spreading activity |
08/23/1989 | EP0329295A1 Renin inhibiting peptides with polar end groups |
08/23/1989 | EP0329185A2 Alteration of pharmacokinetics of proteins by charge modification |
08/23/1989 | EP0328978A2 Renin-inhibiting amino acid derivatives |
08/23/1989 | EP0328957A2 Mixture of a thrombolytically acting and an antithrombolytically acting substance |
08/23/1989 | EP0328870A2 Improvement in milk production from lactating ruminants while increasing milk fat and lactose content in the milk produced |
08/23/1989 | EP0328634A1 Pharmaceutical compositions for the treatment of psoriasis |
08/22/1989 | US4859690 Analgesics; gastrointestinal disorders |
08/22/1989 | US4859596 Cloning system for Kluyveromyces species |
08/22/1989 | US4859471 Pancreatic enzyme products and a process for the preparation thereof |
08/22/1989 | US4859452 Methods for the reduction of difluoromethylornithine associated toxicity |
08/22/1989 | US4859449 Modified antibodies for enhanced hepatocyte clearance |
08/22/1989 | CA1258750A1 Renin inhibitors containing 2-substituted statine |
08/22/1989 | CA1258748A1 Renin inhibitory peptides |
08/22/1989 | CA1258639A1 Dentifrice containing stabilized enzyme |
08/22/1989 | CA1258630A1 Compositions and method for improving wound healing |
08/22/1989 | CA1258629A1 Stable erythropoietin preparation and process for formulating the same |
08/22/1989 | CA1258628A1 Method and composition for preventing the adsorption of a medicine |
08/16/1989 | EP0328446A1 Conjugates of vinca derivatives containing a detergent chain in position C-3 |
08/16/1989 | EP0328404A1 Modified antibodies |
08/16/1989 | EP0328403A2 Synthetic peptides related to the HIV-GP120-env-protein, and their use |
08/16/1989 | EP0328390A2 Peptide treatment of refractory infectious diseases |
08/16/1989 | EP0328383A1 Novel coleopteran-active bacillus thuringiensis isolate |
08/16/1989 | EP0328255A1 A medicament for the treatment of a fibrotic disorder, and anti-fibrotic composition |
08/16/1989 | EP0328248A2 Monoclonal antibodies against a follicle-stimulating hormone |
08/16/1989 | EP0328160A1 Amino acid derivatives, process to prepare them, composition containing them and their use |
08/16/1989 | EP0328132A2 Therapeutic agent for thrombocytopenia |
08/16/1989 | EP0328123A1 Heterogeneous, pre-S rich hepatitis B surface antigen |
08/16/1989 | EP0328121A1 Substituted hydrazine mitomycin analogs |
08/16/1989 | EP0328090A2 LHRH analogs |
08/16/1989 | EP0328089A2 Reduced size LHRH analogs |
08/16/1989 | EP0328061A2 Human colony-stimulating factors |